| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4afb8b01aa8de7e0b24a86713b23a18 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44fbd35c6a3382b12e9516403f87aad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e9ee1ee1f2d26d5984e4c614ea023d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d19251935d689345a7ed925e72f46977 |
| publicationDate |
2020-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020207771-A1 |
| titleOfInvention |
A method for determining the likelihood of a patient being responsive to cancer immunotherapy |
| abstract |
The present invention relates to a method for determining the likelihood of a patient being responsive to cancer immunotherapy by determining the amount of T cells expressing the markers PD-1, CTLA-4, TIM-3, and CD38 and the amount of regulatory T cells (T-regs). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112881684-A |
| priorityDate |
2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |